Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Sees Significant Growth in Short Interest

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) saw a significant growth in short interest in February. As of February 13th, there was short interest totaling 15,313 shares, a growth of 59.8% from the January 29th total of 9,581 shares. Based on an average trading volume of 31,836 shares, the short-interest ratio is presently 0.5 days. Approximately 0.4% of the company’s shares are short sold. Approximately 0.4% of the company’s shares are short sold. Based on an average trading volume of 31,836 shares, the short-interest ratio is presently 0.5 days.

Institutional Investors Weigh In On Invesco Pharmaceuticals ETF

Institutional investors and hedge funds have recently modified their holdings of the stock. IFP Advisors Inc raised its holdings in shares of Invesco Pharmaceuticals ETF by 31.3% during the 4th quarter. IFP Advisors Inc now owns 440 shares of the company’s stock valued at $46,000 after buying an additional 105 shares during the period. AE Wealth Management LLC grew its position in Invesco Pharmaceuticals ETF by 21.5% in the second quarter. AE Wealth Management LLC now owns 717 shares of the company’s stock valued at $57,000 after acquiring an additional 127 shares in the last quarter. International Assets Investment Management LLC purchased a new stake in shares of Invesco Pharmaceuticals ETF during the fourth quarter valued at approximately $64,000. PNC Financial Services Group Inc. lifted its position in shares of Invesco Pharmaceuticals ETF by 29.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 1,325 shares of the company’s stock worth $139,000 after purchasing an additional 300 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Invesco Pharmaceuticals ETF in the fourth quarter valued at $167,000.

Invesco Pharmaceuticals ETF Stock Down 0.5%

Shares of PJP stock traded down $0.49 during mid-day trading on Friday, reaching $108.37. The company’s stock had a trading volume of 17,633 shares, compared to its average volume of 56,134. The firm has a market capitalization of $413.97 million, a PE ratio of 15.59 and a beta of 0.50. The company’s 50 day simple moving average is $106.92 and its 200-day simple moving average is $100.37. Invesco Pharmaceuticals ETF has a 12-month low of $72.25 and a 12-month high of $110.81.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.